Cannabis and Diabetes | Granny Storm Crow’s MMJ Reference

Here is a very comprehensive list of research articles, abstracts, news stories and other references about cannabis and diabetes. These links are listed under ‘Diabetes’ in Granny Storm Crow’s MMJ Reference List. The author, Granny Storm Crow, has spent the better part of a lifetime collecting and sharing objective cannabis research and information. In her own words:

“It is time for us to demand a change in the laws on cannabis! We must keep telling the truth, keep presenting the facts to our friends and our families. The facts are there in PubMed- cannabis IS medicine! Our government lies to us about cannabis! And folks-

If the truth won’t do, then something is wrong!” – Granny Storm Crow

Cannabis and Diabetes Article Abstracts

• Cannabidiol Preserves Retinal Neurons and Reduces Vascular Permeability in Experimental Diabetes (abst – 2004)
• The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats. (abst – 2004)
• Gpr40 Gene Expression in Human Pancreas and Insulinoma (abst – 2005)
• The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse (abst – 2005)
• Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. (abst – 2006)
• Expression of the Gene for a Membrane-bound Fatty Acid Receptor in the Pancreas and Islet Cell Tumours in Humans: Evidence for Gpr40 Expression in Pancreatic Beta Cells and Implications for Insulin Secretion. (abst – 2006)
• The Cannabinergic System as a Target for Anti-inflammatory Therapies (abst – 2006)
• Role of cannabinoid CB2 receptors in glucose homeostasis in rats (abst – 2007)
• The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells (abst – 2007)
• Anticoagulant Effects of a Cannabis Extract in an Obese Rat Model (abst – 2007)
• Presence of functional cannabinoid receptors in human endocrine pancreas. (abst – 2008)
• Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes (abst – 2009)
• Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. (abst – 2009)
• Beneficial effects of a Cannabis sativa extract on diabetes induced neuropathy and oxidative stress. (abst – 2009)
• Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. (abst – 2010)
• AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. (abst – 2010)
• Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. (abst – 2010)
• GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. (abst – 2010)
• Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation. (abst – 2010)
• Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. (abst – 2011)
• Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis (abst – 2011)
• Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells (abst – 2011)
• Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. (abst – 2011)
• Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans. (abst – 2011)
• A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. (abst – 2011)
• Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy. (abst – 2011)
• Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes. (abst – 2011)
• Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. (abst – 2011)
• Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression. (abst – 2011)
• GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms (abst – 2011)
• Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation (abst – 2011)
• The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (abst – 2011)
• The Endocannabinoid System: Plant-Derived Cannabinoids in Diabetes and Diabetic Complications. (abst – 2011) 

Cannabis and Diabetes Full Articles

• Cannabidiol lowers incidence of diabetes in non-obese diabetic mice (full – 2005)
• Activation of the Peripheral Endocannabinoid System in Human Obesity (full – 2005)
• Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes (full – 2006)
• Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic Cells and in Obesity and Hyperglycemia (full – 2006)
• Weight Control in Individuals With Diabetes (full – 2006)
• Expression of Cannabinoid CB1 Receptors in Models of Diabetic Neuropathy (full – 2007)
• Cannabidiol attenuates high-induced endothelial cell inflammatory response and barrier disruption (full – 2007)
• US Patent Application 20070099987 – Treating or preventing diabetes with cannabidiol (full – 2007)
• Cannabidiol arrests onset of autoimmune diabetes in NOD mice (full – 2007)
• Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full – 2008)
• The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids (full – 2008)
• GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity (full – 2008)
• Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full – 2008)
• Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. (full – 2008)
• Endocannabinoids and the Control of Energy Homeostasis (full – 2008)
• Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full – 2008)
• Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. (full – 2009)
• Cannabinoids as novel anti-inflammatory drugs. (full – 2009)
• Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis (full – 2009)
• The endocanabinnoid system and diabetes – critical analyses of studies conducted with rimonabant (full – 2009)
• Expression and function of cannabinoid receptors in mouse islets. ( full – 2010)
• Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full – 2010)
• Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full – 2010)
• Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy (full – 2010)
• Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells (full – 2010)
• Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients (full – 2010)
• Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. (full – 2010)
• Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes. (full – 2010)
• Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy (full – 2010)
• Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes? (full – 2010)
• Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice (full– 2011)
• Role for cannabinoid receptors in human proximal tubular hypertrophy. (full– 2011)

Cannabis and Diabetes News and Other Reference

• Non-Psychoactive Cannabinoid Reduces Incidence Of Diabetes, Study Says (news – 2006)
• Marijuana Compound May Help Stop Diabetic Retinopathy (news – 2006)
• Cannabidiol, a marijuana compound, may help stop diabetic retinopathy (news – 2006)
• Marijuana Compound Offers Hope In Diabetic Retinopathy Prevention (news – 2006)
• Cannabidiol reduces the development of diabetes in an animal study (news – 2006)
• Getting Eye On Cannabinoids (news – 2006)
• Marijuana compound could prevent eye damage in diabetics (news – 2006)
• Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug (news – 2009)
• Pot Compound Mitigates Diabetic Cardiomyopathy (news – 2010)
• Cannabinoids inhibit and may prevent neuropathic pain in diabetes. (news – 2010)
• Lab Notes: Pot Has Benefits for Diabetic Hearts (news – 2010)
• Takeda moves potential first-in-class diabetes drug into phase III (news – 2011)

Other Weedist Granny Storm Crow Links

• Cannabis and Nutrition | Granny Storm Crow’s MMJ Reference
• Cannabis and Heart Disease | Granny Storm Crow’s MMJ Reference
• Cannabis and Driving | Granny Storm Crow’s MMJ Reference
• Cannabis and Nausea | Granny Storm Crow’s MMJ Reference
• Cannabis and Lung Cancer | Granny Storm Crow’s MMJ Reference
• Cannabis and Addiction | Granny Storm Crow’s MMJ Reference
• Granny Storm Crow’s List Archives

View all “Granny Storm Crow’s MMJ Reference” posts on Weedist →